5 minute read
Feb. 25, 2023

A protein-protein interaction inhibitor for a challenging-to-drug master transcription factor


oral BCL6 BTB inhibitor promising in vitro safety + oral mouse/dog PK data from virtual screen + SBDD ACS Med. Chem. Lett., January 12, 2023 OICR, Toronto, CA (Janssen)


MOTY Nominees

Molecule of the Year